Acute Lymphoblastic Leukemia: Risk Stratification
1 Views
administrator
06/15/23
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
-
Category
Show more
Facebook Comments
No comments found